In what it is calling an action "," the FDA has announced taking an "important step" that shows its commitment "to making sure that all tobacco products that are sold and distributed to the public meet the requirements of the Family Smoking Prevention and Tobacco Control Act (Tobacco Control Act)." According to the FDA, this bold new action is necessary because: "Ensuring compliance with the law is critical to FDA’s mission to protect public health."

What the FDA is stating is that it does not believe that it would be any worse for individual X to resume cigarette smoking than for her to remain an ex-smoker by continuing to vape. The FDA is stating that it is aware of no evidence to suggest that returning to cigarette smoking would be an unwise decision for this individual.

Moreover, the FDA's actions are sending the wrong message to the public. First, the FDA is indicating to the public that there is such a thing as a safer cigarette. The FDA is insinuating that even small changes in cigarette design can result in drastic differences in the public health safety of cigarettes.

2. Stan Glantz announcement list

These flaws are also noted by Dr. Robert West, director of tobacco research at University College London, who that: "the study was not able to assess whether or not for cancer patients who smoke using an e-cigarette to try and quit is beneficial "because the sample could consist of e-cigarette users who had already failed in a quit attempt, so all those who would have succeeded already would be ruled out"."

LAST：Cylapex 808d cartomizer wholesale and 808d cartomizer for wholesale, fast delievery and guaranteed quality |NEXT：Newest and latest vapor bluetooth, bluetooth electronic cigarette,bluetooth e cig